OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Thrombotic and bleeding complications in patients with chronic lymphocytic leukemia and severe COVID-19: a study of ERIC, the European Research Initiative on CLL
Darko Antić, Nataša Milić, Thomas Chatzikonstantinou, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 8
Darko Antić, Nataša Milić, Thomas Chatzikonstantinou, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 8
Showing 8 citing articles:
The evolving landscape of COVID ‐19 and post‐COVID condition in patients with chronic lymphocytic leukemia: A study by ERIC , the European research initiative on CLL
Andrea Visentin, Thomas Chatzikonstantinou, Lydia Scarfò, et al.
American Journal of Hematology (2023) Vol. 98, Iss. 12, pp. 1856-1868
Open Access | Times Cited: 14
Andrea Visentin, Thomas Chatzikonstantinou, Lydia Scarfò, et al.
American Journal of Hematology (2023) Vol. 98, Iss. 12, pp. 1856-1868
Open Access | Times Cited: 14
Causal Effects of COVID-19 on the Risk of Thrombosis: A Two-Sample Mendel Randomization Study
Zhengran Li, Minghui Zeng, Tong Wu, et al.
Thrombosis and Haemostasis (2024) Vol. 124, Iss. 08, pp. 709-720
Open Access | Times Cited: 3
Zhengran Li, Minghui Zeng, Tong Wu, et al.
Thrombosis and Haemostasis (2024) Vol. 124, Iss. 08, pp. 709-720
Open Access | Times Cited: 3
The Safety of Novel Therapies in Chronic Lymphocytic Leukemia in the Era of Intermittent Fasting: A Pharmacology-Based Review
Maria Benkhadra, N. Fituri, Soha Aboukhalaf, et al.
Cancers (2024) Vol. 16, Iss. 11, pp. 2079-2079
Open Access | Times Cited: 2
Maria Benkhadra, N. Fituri, Soha Aboukhalaf, et al.
Cancers (2024) Vol. 16, Iss. 11, pp. 2079-2079
Open Access | Times Cited: 2
Tixagevimab/Cilgavimab as pre-exposure prophylaxis against SARS-CoV-2 in patients with hematological malignancies
Francesco Angotzi, Marco Petrella, Tamara Berno, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 7
Francesco Angotzi, Marco Petrella, Tamara Berno, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 7
Realizing precision medicine in chronic lymphocytic leukemia: Remaining challenges and potential opportunities
Κώστας Σταματόπουλος, Šárka Pavlová, Othman Al‐Sawaf, et al.
HemaSphere (2024) Vol. 8, Iss. 7
Open Access | Times Cited: 1
Κώστας Σταματόπουλος, Šárka Pavlová, Othman Al‐Sawaf, et al.
HemaSphere (2024) Vol. 8, Iss. 7
Open Access | Times Cited: 1
Outcomes of COVID-19 infection in patients with chronic lymphocytic leukemia: a systematic review and meta-analysis
Mohammad Amin Akbarzadeh, Yosra Vaez-Gharamaleki, Farid Jahanshahlou, et al.
Revista da Associação Médica Brasileira (2024) Vol. 70, Iss. 8
Open Access | Times Cited: 1
Mohammad Amin Akbarzadeh, Yosra Vaez-Gharamaleki, Farid Jahanshahlou, et al.
Revista da Associação Médica Brasileira (2024) Vol. 70, Iss. 8
Open Access | Times Cited: 1
A Retrospective Study on the Efficacy of Subcutaneous Immunoglobulin as Compared to Intravenous Formulation in Patients with Chronic Lymphocytic Leukemia and Secondary Antibody Deficiency
Andrea Visentin, Maria Chiara Molinari, Stefano Pravato, et al.
Current Oncology (2022) Vol. 30, Iss. 1, pp. 274-283
Open Access | Times Cited: 8
Andrea Visentin, Maria Chiara Molinari, Stefano Pravato, et al.
Current Oncology (2022) Vol. 30, Iss. 1, pp. 274-283
Open Access | Times Cited: 8
Editorial: Covid-19 therapies in patients with hematologic malignancies
Andrea Visentin, Massimo Gentile
Frontiers in Oncology (2024) Vol. 14
Open Access
Andrea Visentin, Massimo Gentile
Frontiers in Oncology (2024) Vol. 14
Open Access
